Cystic Pancreatic Neuroendocrine Tumors: A Clinicopathologic Study

Pancreatic neuroendocrine tumors (PanNETs) are typically solid neoplasms but in rare instances may present as cystic lesions. This unusual presentation can make clinical diagnosis challenging. In addition, the clinical and histopathologic characteristics of cystic PanNETs are poorly defined. We identified 53 cystic PanNETs in our single-institution experience of 491 surgically resected PanNETs. Similar to solid PanNETs, cystic PanNETs developed with an equal sex distribution and over a wide age range (23 to 91 y; mean, 52 y). The unusual cystic appearance made radiologic differentiation from other cystic pancreatic neoplasms difficult with a misdiagnosis in 23 of 53 (43%) cases. An association between cystic PanNETs and multiple endocrine neoplasia type 1 or multifocal disease [5 of 53 (9%) and 7 of 53 (13%), respectively] was not observed as compared with solid PanNETs (P=0.34 and P=0.31, respectively). Grossly, cystic PanNETs were predominantly located in the tail of the pancreas (n=28, 53%) and were similar in size (mean, 3.3 cm) to solid PanNETs (mean, 4.1 cm; P=0.12). All cysts were unilocular (n=53, 100%) and filled with clear to straw-colored fluid. Larger cysts were sometimes noted to be hemorrhagic. Histologically, the cysts were lined by a thin fibrous band that separated the cyst from the neoplastic cells. In comparison with their solid counterparts, cystic PanNETs were less likely to demonstrate tumor necrosis (6%; P=0.04), perineural invasion (8%; P<0.001), vascular invasion (4%; P<0.001), regional lymph node metastasis (13%; P<0.001), and synchronous distant metastasis (4%; P=0.015). The neoplastic cells of the cystic PanNETs were well differentiated (n=53, 100%) with a low mitotic rate and low Ki-67 proliferation index (range, 0.2% to 11%; mean, 1.8%). On the basis of both the American Joint Cancer Committee and European Neuroendocrine Tumor Society staging systems, the majority of cystic PanNETs presented at a lower pathologic stage as compared with solid PanNETs. In summary, cystic PanNETs are a distinctive subgroup of PanNETs with unique clinical, radiographic, and pathologic features.

[1]  Laura H. Tang,et al.  The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis. , 2012, Surgery.

[2]  C. Willett,et al.  Clinical Investigation : Gastrointestinal Cancer Resected Pancreatic Neuroendocrine Tumors : Patterns of Failure and Disease-Related Outcomes With or Without Radiotherapy , 2012 .

[3]  João Niza,et al.  Neuroendocrine neoplasms of the pancreas: clinical, pathologic and cross-sectional imaging analysis according to the 4 th edition of the World Health Organization (WHO) classification of tumors of the digestive system , 2012 .

[4]  A. Maitra,et al.  Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways , 2011, Proceedings of the National Academy of Sciences.

[5]  R. McLendon,et al.  Altered Telomeres in Tumors with ATRX and DAXX Mutations , 2011, Science.

[6]  Toby C. Cornish,et al.  Hyaline Globules in Neuroendocrine and Solid-pseudopapillary Neoplasms of the Pancreas: A Clue to the Diagnosis , 2011, The American journal of surgical pathology.

[7]  Michael A. Choti,et al.  DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors , 2011, Science.

[8]  A. Scarpa,et al.  Pancreatic Cystic Endocrine Tumors: A Different Morphological Entity Associated with a Less Aggressive Behavior , 2010, Neuroendocrinology.

[9]  E. Baudin,et al.  Daily Oral Everolimus Activity in Patients with Metastatic Pancreatic Neuroendocrine Tumors after Failure of Cytotoxic Chemotherapy: A Phase II Trial , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Manal M. Hassan,et al.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  D. Sahani,et al.  Cystic pancreatic endocrine neoplasms: a distinct tumor type? , 2008, Journal of the American College of Surgeons.

[12]  M. Mino‐Kenudson,et al.  Mucinous Cystic Neoplasm of the Pancreas is Not an Aggressive Entity: Lessons From 163 Resected Patients , 2008, Annals of surgery.

[13]  R. Jensen,et al.  Gastroenteropancreatic neuroendocrine tumours. , 2008, The Lancet. Oncology.

[14]  O. Basturk,et al.  Intraductal and Papillary Variants of Acinar Cell Carcinomas: A New Addition to the Challenging Differential Diagnosis of Intraductal Neoplasms , 2007, The American journal of surgical pathology.

[15]  B. Wiedenmann,et al.  Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: Why Such Guidelines and How We Went about It , 2007, Neuroendocrinology.

[16]  B. Weinhold Epigenetics: The Science of Change , 2006, Virchows Archiv.

[17]  P. Chow,et al.  Clinico-pathological features of cystic pancreatic endocrine neoplasms and a comparison with their solid counterparts. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[18]  S. Chari,et al.  International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas , 2006, Pancreatology.

[19]  K. Ohtomo,et al.  Cystic islet cell tumors: Radiologic findings in three cases , 1994, Abdominal Imaging.

[20]  J. Cameron,et al.  Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. , 2002, The American journal of pathology.

[21]  H. Pitt,et al.  Cystic pancreatic neuroendocrine tumors: Is preoperative diagnosis possible? , 2002, Journal of Gastrointestinal Surgery.

[22]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[23]  N. Nagahara,et al.  Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. , 2001, Cancer research.

[24]  J. Dumortier,et al.  Cystic Endocrine Tumors of the Pancreas: Clinical, Radiologic, and Histopathologic Features in 13 Cases , 2001, The American journal of surgical pathology.

[25]  E. Dimagno,et al.  Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? , 2000, Annals of surgery.

[26]  R. Reznek,et al.  Cystic islet cell tumors of the pancreas. , 1998, AJR. American journal of roentgenology.

[27]  T. Hasebe,et al.  Intraductal papillary tumors and mucinous cystic tumors of the pancreas: clinicopathologic study of 38 cases. , 1997, Human pathology.

[28]  A. Dachman,et al.  Islet cell tumors of the pancreas: pathologic-imaging correlation among size, necrosis and cysts, calcification, malignant behavior, and functional status. , 1995, AJR. American journal of roentgenology.

[29]  P. Pour,et al.  Plaeomorphic nonfunctioning islet cell tumor of the pancreas , 1995, International journal of pancreatology : official journal of the International Association of Pancreatology.

[30]  M. Fukayama,et al.  A case of malignant cystic endocrine tumor of the pancreas. , 1987, The American journal of gastroenterology.

[31]  A. Zontini [Study of cysts of the pancreas]. , 1958, Acta chirurgica Italica.

[32]  K. T. Steigelman Tumors of the pancreas. , 1951, The Journal of the American Osteopathic Association.